Tags

Type your tag names separated by a space and hit enter

Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period.
J Endocrinol Invest. 2021 Aug; 44(8):1689-1698.JE

Abstract

CONTEXT

The COVID-19 outbreak in Italy is the major concern of Public Health in 2020: measures of containment were progressively expanded, limiting Outpatients' visit.

OBJECTIVE

We have developed and applied an emergency plan, tailored for Outpatients with endocrine diseases.

DESIGN

Cross-sectional study from March to May 2020.

SETTING

Referral University-Hospital center.

PATIENTS

1262 patients in 8 weeks.

INTERVENTIONS

The emergency plan is based upon the endocrine triage, the stay-safe procedures and the tele-Endo. During endocrine triage every patient was contacted by phone to assess health status and define if the visit will be performed face-to-face (F2F) or by tele-Medicine (tele-Endo). In case of F2F, targeted stay-safe procedures have been adopted. Tele-Endo, performed by phone and email, is dedicated to COVID-19-infected patients, to elderly or frail people, or to those with a stable disease.

MAIN OUTCOME MEASURE

To assess efficacy of the emergency plan to continue the follow-up of Outpatients.

RESULTS

The number of visits cancelled after endocrine triage (9%) is lower than that cancelled independently by the patients (37%, p < 0.001); the latter reduced from 47 to 19% during the weeks of lockdown (p = 0.032). 86% of patients contacted by endocrine-triage received a clinical response (F2F and tele-Endo visits). F2F visit was offered especially to young patients; tele-Endo was applied to 63% of geriatric patients (p < 0.001), visits' outcome was similar between young and aged patients.

CONCLUSIONS

The emergency plan respects the WHO recommendations to limit viral spread and is useful to continue follow-up for outpatients with endocrine diseases.

Authors+Show Affiliations

Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy. filippo.ceccato@unipd.it. Department of Neuroscience DNS, University of Padova, Padova, Italy. filippo.ceccato@unipd.it.Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy.Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy.Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy.Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy. Department of Surgical Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Padova, Italy.Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy.Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy.Department of Directional Hospital Management, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Padova, Italy.Department of Directional Hospital Management, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Padova, Italy.Department of Directional Hospital Management, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Padova, Italy.Department of Directional Hospital Management, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Padova, Italy.Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, European Reference Network On Rare Endocrine Conditions (endoERN) Center of Padova, Via Ospedale Civile, 105, 35128, Padova, Italy.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33355915

Citation

Ceccato, F, et al. "Tele-medicine Versus Face-to-face Consultation in Endocrine Outpatients Clinic During COVID-19 Outbreak: a Single-center Experience During the Lockdown Period." Journal of Endocrinological Investigation, vol. 44, no. 8, 2021, pp. 1689-1698.
Ceccato F, Voltan G, Sabbadin C, et al. Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period. J Endocrinol Invest. 2021;44(8):1689-1698.
Ceccato, F., Voltan, G., Sabbadin, C., Camozzi, V., Merante Boschin, I., Mian, C., Zanotto, V., Donato, D., Bordignon, G., Capizzi, A., Carretta, G., & Scaroni, C. (2021). Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period. Journal of Endocrinological Investigation, 44(8), 1689-1698. https://doi.org/10.1007/s40618-020-01476-2
Ceccato F, et al. Tele-medicine Versus Face-to-face Consultation in Endocrine Outpatients Clinic During COVID-19 Outbreak: a Single-center Experience During the Lockdown Period. J Endocrinol Invest. 2021;44(8):1689-1698. PubMed PMID: 33355915.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period. AU - Ceccato,F, AU - Voltan,G, AU - Sabbadin,C, AU - Camozzi,V, AU - Merante Boschin,I, AU - Mian,C, AU - Zanotto,V, AU - Donato,D, AU - Bordignon,G, AU - Capizzi,A, AU - Carretta,G, AU - Scaroni,C, Y1 - 2020/12/23/ PY - 2020/09/25/received PY - 2020/11/24/accepted PY - 2020/12/29/pubmed PY - 2021/7/22/medline PY - 2020/12/28/entrez KW - COVID-19 KW - Endocrine unit KW - Hub-spoke organization KW - Telemedicine SP - 1689 EP - 1698 JF - Journal of endocrinological investigation JO - J Endocrinol Invest VL - 44 IS - 8 N2 - CONTEXT: The COVID-19 outbreak in Italy is the major concern of Public Health in 2020: measures of containment were progressively expanded, limiting Outpatients' visit. OBJECTIVE: We have developed and applied an emergency plan, tailored for Outpatients with endocrine diseases. DESIGN: Cross-sectional study from March to May 2020. SETTING: Referral University-Hospital center. PATIENTS: 1262 patients in 8 weeks. INTERVENTIONS: The emergency plan is based upon the endocrine triage, the stay-safe procedures and the tele-Endo. During endocrine triage every patient was contacted by phone to assess health status and define if the visit will be performed face-to-face (F2F) or by tele-Medicine (tele-Endo). In case of F2F, targeted stay-safe procedures have been adopted. Tele-Endo, performed by phone and email, is dedicated to COVID-19-infected patients, to elderly or frail people, or to those with a stable disease. MAIN OUTCOME MEASURE: To assess efficacy of the emergency plan to continue the follow-up of Outpatients. RESULTS: The number of visits cancelled after endocrine triage (9%) is lower than that cancelled independently by the patients (37%, p < 0.001); the latter reduced from 47 to 19% during the weeks of lockdown (p = 0.032). 86% of patients contacted by endocrine-triage received a clinical response (F2F and tele-Endo visits). F2F visit was offered especially to young patients; tele-Endo was applied to 63% of geriatric patients (p < 0.001), visits' outcome was similar between young and aged patients. CONCLUSIONS: The emergency plan respects the WHO recommendations to limit viral spread and is useful to continue follow-up for outpatients with endocrine diseases. SN - 1720-8386 UR - https://www.unboundmedicine.com/medline/citation/33355915/Tele_medicine_versus_face_to_face_consultation_in_Endocrine_Outpatients_Clinic_during_COVID_19_outbreak:_a_single_center_experience_during_the_lockdown_period_ L2 - https://link.springer.com/article/10.1007/s40618-020-01476-2 DB - PRIME DP - Unbound Medicine ER -